# OnCo record patritumab-deruxtecan (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/patritumab-deruxtecan/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "patritumab-deruxtecan" ;
  schema:name "Patritumab deruxtecan"@en ;
  schema:description "A HER3-directed ADC with Enhertu's payload, active in lung and all subtypes of breast cancer, but with a bumpy regulatory road."@en ;
  schema:url <https://onco.cc/drugs/patritumab-deruxtecan/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=HER3-DXd> ;
  onco:status "phase-3" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her3/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/>, <https://onco.cc/companies/merck/> ;
  onco:terms <https://onco.cc/terms/ggfg/> ;
  onco:trials <https://onco.cc/trials/nct04619004/>, <https://onco.cc/trials/nct06172478/>, <https://onco.cc/trials/nct06731907/>, <https://onco.cc/trials/nct06469944/>, <https://onco.cc/trials/nct07286149/>, <https://onco.cc/trials/nct07060807/>, <https://onco.cc/trials/nct06797635/>, <https://onco.cc/trials/nct06596694/>, <https://onco.cc/trials/nct06686394/>, <https://onco.cc/trials/nct06941272/> .